biotechnolog compani file registr statement
secur exchang commiss offer
three million common share $ 17 $ 20 share
nine million share outstand
offer would valu boston univers stake
would 69 % offer $ 140 million
$ 165 million univers invest $ 85 million
seragen develop anti-canc drug although mani
colleg made venture-capit invest part
overal strategi critic contend boston univers
invest seragen larg riski unproven
compani especi given relat small size
univers endow
univers offici defend stake argu
seragen potenti becom major drug compani
declin comment offer yesterday
seragen said experiment drug treat
certain blood-cel cancer show milder side effect
exist medicin show anti-tumor effect
clinic studi cancer expert caution time
howev data need draw conclus
drug effect
share offer sale seragen 2.4
million offer u.s. 600,000
offer outsid u.s. compani grant
underwrit option purchas mani 450,000
addit share cover overallot
manag underwrit goldman sach co.
kidder peabodi co. intern unit
